On the contrast, consistent with FACS apoptosis assay, a significant difference in cell proliferation and metabolic flux was observed for SK-N-BE2 cells treated with doxorubicin in the presence of cathepsin inhibitors compared to doxorubicin treatment alone (Figure 4B).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}